Psilocybin

This JAMA Insights discusses the medical use of psilocybin, particularly for depression treatment, including emerging potential indications, safety, and future use.

Authors

Institutions

Publication Details

Journal
JAMA
Published
2026-09-10
DOI
https://doi.org/10.1001/jama.2026.11874
Citations
1
Primary Topic
Psychedelics and Drug Studies
Type
article
Field-Weighted Citation Impact
10.24
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
article

Psilocybin

M. Ishrat Husain, Joshua D. Rosenblat
1 citations
JAMA
Psychedelics and Drug Studies
10.24
article

Psilocybin

M. Ishrat Husain, Joshua D. Rosenblat
article en
1 citations

Abstract

This JAMA Insights discusses the medical use of psilocybin, particularly for depression treatment, including emerging potential indications, safety, and future use.

JAMA
Centre for Addiction and Mental Health (CA), University of Toronto (CA), Ontario Brain Institute (CA)
Good health and well-being
Openalex Percentile: Top 2%
Psychedelics and Drug Studies
10.24
DOISourceOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Psilocybin — M. Ishrat Husain, Joshua D. Rosenblat · JAMA (2026) | TGRS Research Map | TGRS